MyFinsight
Home
Blog
About
Proceeds from registered
direct offerings
$5,293K
Proceeds from warrant
exercise
$3,577K
Proceeds from sale of
stock, net of issuance...
$537K
(-29.80%↓ Y/Y)
Net cash provided by
financing activities
$8,786K
(765.62%↑ Y/Y)
Canceled cashflow
$621K
Net increase
(decrease) in cash and cash...
$4,084K
(433.39%↑ Y/Y)
Canceled cashflow
$4,702K
Repayment of debt
obligation
$621K
something is missing
$736K
Depreciation and
amortization
$571K
Net cash used in
operating activities
-$4,590K
(-17.93%↓ Y/Y)
Net cash (used in)
provided by investing...
-$112K
(-106.78%↓ Y/Y)
Canceled cashflow
$1,307K
Net loss
-$3,788K
(41.71%↑ Y/Y)
Accounts payable and
accrued expenses
-$1,359K
Purchase of patent and
trademark rights
$112K
(-60.42%↓ Y/Y)
Abandonment and expiration
of patents and...
-$673K
(-209.43%↓ Y/Y)
Lease liability
-$50K
(35.90%↑ Y/Y)
Prepaid expenses and
other assets
$27K
(400.00%↑ Y/Y)
Back
Back
Cash Flow
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. (AIM)
source: myfinsight.com